Remdesivir (GS-5734)

製品コードS8932 バッチS893201

印刷

化学情報

Synonyms

N/A

Storage
(From the date of receipt)

3 years -20°C powder

化学式

C₂₇H₃₅N₆O₈P

分子量

602.58

CAS No.

1809249-37-3

Solubility (25°C)*

体外

DMSO

100 mg/mL (165.95 mM)

Ethanol

16 mg/mL (26.55 mM)

Water

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension

CMC-NA

≥5mg/ml

Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	Remdesivir (GS-5734), a monophosphoramidate prodrug of an adenosine analog, is an investigational broad-spectrum antiviral agent with in vitro activity against multiple RNA viruses, including Ebola and CoV.
in vitro	Remdesivir (GS-5734) exhibits antiviral activity against multiple variants of EBOV in cell-based assays (EC50=0.06-0.14 μM) and broad-spectrum antiviral activity in vitro against other pathogenic RNA viruses. ^[1] This compound acts as a broad-spectrum therapeutic to protect against CoVs with EC50 of 0.03 μM for murine hepatitis virus in delayed brain tumor cells and 0.074 μM for SARS-CoV and MERS-CoV in HAE cells.^[2]
in vivo	Regardless of the time of initiation, treatment with Remdesivir (GS-5734) confers improved survival when administered at 3 mg/kg. All animals in which 10 mg/kg treatment is initiated 3 days after virus exposure survive to the end of the in-life phase. However, the antiviral effects are consistently greater in animals administered repeated 10 mg/kg doses. The 10 mg/kg D3 (administered beginning 3 days after virus exposure) regimen is associated with amelioration of EVD-related clinical disease signs and markers of coagulopathy and end organ pathophysiology.^[1]

製品説明

Remdesivir (GS-5734), a monophosphoramidate prodrug of an adenosine analog, is an investigational broad-spectrum antiviral agent with in vitro activity against multiple RNA viruses, including Ebola and CoV.

in vitro

Remdesivir (GS-5734) exhibits antiviral activity against multiple variants of EBOV in cell-based assays (EC50=0.06-0.14 μM) and broad-spectrum antiviral activity in vitro against other pathogenic RNA viruses. ^[1]

This compound acts as a broad-spectrum therapeutic to protect against CoVs with EC50 of 0.03 μM for murine hepatitis virus in delayed brain tumor cells and 0.074 μM for SARS-CoV and MERS-CoV in HAE cells.^[2]

in vivo

Regardless of the time of initiation, treatment with Remdesivir (GS-5734) confers improved survival when administered at 3 mg/kg. All animals in which 10 mg/kg treatment is initiated 3 days after virus exposure survive to the end of the in-life phase. However, the antiviral effects are consistently greater in animals administered repeated 10 mg/kg doses. The 10 mg/kg D3 (administered beginning 3 days after virus exposure) regimen is associated with amelioration of EVD-related clinical disease signs and markers of coagulopathy and end organ pathophysiology.^[1]

プロトコル(参考用のみ)

細胞アッセイ	細胞株	HeLa cells
	濃度	0.14 uM
	反応時間	72 h
	実験の流れ	Cells were treated with various concentrations of Remdesivir (GS-5734).
動物実験	動物モデル	Rhesus monkeys (Macaca mulatta)
	投薬量	3 mg / kg, 10 mg / kg
	投与方法	IV

参考

https://pubmed.ncbi.nlm.nih.gov/26934220/
https://pubmed.ncbi.nlm.nih.gov/29511076/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Exploring the Therapeutic Potential of Cordyceps Mushroom on SARS-CoV-2 Using Virtual Screening against Mpro and In Vitro Validation of Cordycepin [ J Microbiol Biotechnol, 2025, 35:e2411063]	PubMed: 40147924
Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs [ Chem Pharm Bull (Tokyo), 2025, 73(4):355-368]	PubMed: 40240159
Andrographolide attenuates SARS-CoV-2 infection via an up-regulation of glutamate-cysteine ligase catalytic subunit (GCLC) [ Phytomedicine, 2024, 136:156279]	PubMed: 39631298
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance [ Antiviral Res, 2024, 225:105840]	PubMed: 38438015
Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes [ Int J Mol Sci, 2024, 25(3)1427]	PubMed: 38338708
Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes [ Int J Mol Sci, 2024, 24;25(3):1427.]	PubMed: 38338708
Development of a Měnglà virus minigenome and comparison of its polymerase complexes with those of other filoviruses [ Virol Sin, 2024, 39(3):459-468]	PubMed: 38782261
The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association [ J Virol, 2024, 98(4):e0156523]	PubMed: 38445884
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological Profiling [ Viruses, 2024, 16(7)1158]	PubMed: 39066320
A high-throughput response to the SARS-CoV-2 pandemic [ SLAS Discov, 2024, 29(5):100160]	PubMed: 38761981

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。